A selective inhibitor of oncogenic JNK signalling perturbs metastatic outgrowth of triple-negative breast cancer through metabolic blockade
Sharissa L. Latham, Yolande E. I. O’Donnell, Oscar Girgis-Cook…·David R. Croucher
The paper identifies a selective JNK inhibitor that blocks metastasis in triple-negative breast cancer by targeting metabolic pathways.